# Efficacy and Safety of memanTine in the Treatment Of Frequently symPtomatic Atrial Premature Beats

> **NCT06501638** · PHASE2 · COMPLETED · sponsor: **Shanghai East Hospital** · enrollment: 256 (actual)

## Conditions studied

- Atrial Premature Beats, Contractions, or Systoles

## Interventions

- **DRUG:** Memantine Hydrochloride 10 MG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06501638
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-29
- **Primary completion:** 2025-03-21
- **Final completion:** 2025-05-16
- **Target enrollment:** 256 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06501638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06501638, "Efficacy and Safety of memanTine in the Treatment Of Frequently symPtomatic Atrial Premature Beats". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06501638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*